Evaluation of renal function and renal risk in the twenty-first century

Programme

    December 4, 2015

    EVALUATING KIDNEY FUNCTION IN DIABETES AND OBESITY

    1. 08:30Welcome-IntroductionEsteban Porrini - Spain
    2. 08:45 Opening Lecture :Should we still believe in RCTs in Nephrology and why so many have failed?Giuseppe Remuzzi - Italy

      ROUND TABLE: THE KIDNEY IN DIABETES AND OBESITY.

    1. 09:30The Fatty Kidney: Obesity and renal disease.Manuel Praga - Spain
    2. 09:50The hyperfiltering kidneyRoberto Trevisan - Italy
    3. 10:10Weight and weight loss: The CRESO studiesManuela Abbate - Italy
    4. 10:30Discussion
    5. 11:00Coffee break

      6. MEASURING AND ESTIMATING RENAL FUCTION AND DISEASE PROGRESSIONPiero Ruggenenti - Italy

    6. 11:30Renal disease progression: Diabetes, Obesity …or a little bit of both?Piero Ruggenenti
    7. 12:00GFR and GFR decline in Diabetes: Can we estimate it?Esteban Porrini
    8. 12:30Lunch break

      GFR ESTIMATION: Methodological ImplicationsAiko de Vries - The Netherlands

    1. 14:30Why serum creatinine and cystatine-based equations fail to estimate true GFR?Aiko de Vries
    2. 14:50Evaluating the performance of GFR prediction equations: The role of agreement methods for continuous variablesEsteban Porrini

      GFR ESTIMATION: Clinical ImplicationsDavid Warnock - USA

    1. 15:20Drug dosing: Any step forward 60-years post-Effersoe?Bo Feldt-Rasmussen - Denmark
    2. 15:45Ageing and CKD stagingDavid Warnock
    3. 16:10CKD Staging in non-Caucasian populations: The Maremar Study.Marc de Broe - Belgium
    4. 16:35Renal and non-renal transplantationMads Hornum - Denmark
    5. 17:00Coffee break
    6. 17:00-18:00ABSTRACTS SESSION
    7. 18:00Closure

    •  

    December 5, 2015

    EVALUATING RENAL RISK IN DIABETES AND OBESITY

    • MINILECTUREGiuseppe Remuzzi

    1. 08:40Micro RNAs in kidney physiology and disease.Ariela Benigni - Italy

      2. PROTEINURIA, PROGRESSION AND NEPHROPROTECTION.Giuseppe Remuzzi

    2. 09:00Regression of proteinuria and the case of kidney repairGiuseppe Remuzzi
    3. 09:30Diabetes, Obesity and Renal Disease: Lessons from Recent Clinical Trials.Piero Ruggenenti
    4. 10:00Coffee break

      5. ROUND TABLE: DO WE HAVE NOVEL BIOMARKERS OF CKD? DO WE NEED THEM?Ariela Benigni - Italy

    5. 10:30Introduction.Radovan Hojs - Slovenia
    6. 10:50Renal lipotoxicityAiko de Vries - The Netherlands
    7. 11:10Kidney Injury marker 1, neutrophil gelatinase-associated lipocalin.Alberto Ortiz - Spain
    8. 11:50Complement activation.Marina Morigi - Italy
    9. 12:10General Discussion

      CLOSING LECTUREGiuseppe Remuzzi

    1. 12:20Estimated GFR and the Global Burden of CKD.Richard Glassock - USA
    2. 13:00Lunch

Download PDF